New Formula & New Presentation

Regulates, compensates, reinforces the bodies defense's

Thymoenzym 2G

INDICATIONS AND DOSAGE:

Below, by way of example and based on broad clinical experience, we show some therapeutic recommended uses in the following areas of specialisation. However, it is up to the physician’s discretion to decide which dosage and which therapeutic plan he will use, according to each specific case and pathology. The clinical experience which this research has yielded supports the combined use thereof with other medications, since the coadjuvant and boosting actions prove the preventive efficacy of Thymoenzym 2G, which does not interact with any other treatment.

Dosage, Frequency and Rate of Treatment:

We have increased the concentration of the injectable presentation to 1000 mg, and of the oral concentration from 250 to 350 mg, thus increasin–g their therapeutic effectiveness.
The usual dose by injection of Thymoenzym 2G Injectable is 2ml every 24 hours; however, it is up to the physician’s discretion to decide which dosage and which therapeutic plan he will use, according to each specific case and pathology.

Degenerative and Specific Diseases:

In the case of diseases caused by cellular immunity failure, the treatment may be more prolonged, at the treating physician’s discretion. The same consideration should be given to cases of abnormal cell tissue development. As an auxiliary medication in the treatment of cancers of various etiologies, it is recommended to administer Thymoenzym 2G for 30 consecutive days, rest 15 days, and resume treatment for another 30 days. Thymoenzym 2G Oral can also be taken, doubling the dose (2 b.i.d. daily) or tripling the dose (3 t.i.d. daily) for the first few months, either alone or in combination with the injections. Patient should be evaluated subsequently. Treatment plan should always be at physician's discretion and according to clinical symptoms. In very prolonged treatments (Hodgkin’s, Kaposi’s Sarcoma), it is recommended to administer one injection five times a week (2ml daily), in combination with the constant use of Thymoenzym 2G Oral.

Internal Medicine, Immunology.
Immune System Disorders:

Primary: The initial recommended dosage is to inject one 2-ml dose from one (1) vial of Thymoenzym 2G 750 mg every other day for 20 days, for a total of 10 injections; this treatment should be taken together with 4 tablets of Thymoenzym 2G Oral 350 mg twice a day (4 b.i.d.) (morning and evening) before meals, taken daily for 60 consecutive days. After the first 2 months of initial treatment have concluded, it is recommended that the patient be clinically evaluated monthly to ascertain whether to continue or discontinue the treatment, as per the physician’s discretion.
Results: Once the first weeks of treatment have been completed, the patient should notice an improvement in his symptoms.

Rheumatoid Arthritis:  The initial recommended dosage is to inject one 2-ml dose from one (1) vial of Thymoenzym 2G 750 mg every other day for 20 days, for a total of 10 injections; this treatment should be taken together with 4 tablets of Thymoenzym 2G Oral 250 mg twice a day (4 b.i.d.) (morning and evening) before meals, taken daily for 60 consecutive days. After the first 2 months of initial treatment have concluded, it is recommended that the patient be clinically evaluated monthly to ascertain whether to continue or discontinue the treatment, as per the physician’s discretion.
Results: Once the first stages of treatment have been completed, the patient should notice an improvement in his symptoms.

AIDS: The initial recommended dosage is to inject one 2-ml dose from one (1) vial of Thymoenzym 2G 750 mg daily for 30 consecutive days, for a total of 30 injections; this treatment should be taken together with 4 tablets of Thymoenzym 2G Oral 350 mg twice a day (4 b.i.d.), taken daily before meals. Patient should be clinically evaluated monthly, checking his T4 levels, to ascertain whether to modify or maintain the treatment, as per the physician’s discretion.
Results: Once the first stages of treatment have been completed, an improvement in should be noted in values as well as in the immune system.

Hypoglobulinemia: The initial recommended dosage is to inject one 2-ml dose of Thymoenzym 2G 750 mg daily for 30 consecutive days, for a total of 30 injections; this treatment should be taken together with 4 tablets of Thymoenzym 2G Oral 350 mg twice a day (4 b.i.d.), taken daily for 30 days. Subsequently, treatment should be continued but decreasing the frequency, injecting one dose of Thymoenzym 2G twice a week (every 3 days) for 30 days, for a total of 10 injections, together with 2 tablets of Thymoenzym 2G Oral twice a day (2 b.i.d.) before meals, taken daily for 30 consecutive days. Patient should be clinically evaluated monthly, checking his blood levels, to ascertain whether to modify or maintain the treatment, as per the physician’s discretion.
Results: Once the first stages of treatment have been completed, the patient should notice an improvement in his symptoms.

Down’s Syndrome: The initial recommended dosage is to inject a 2-ml dose from one (1) vial of Thymoenzym 2G 750 mg every other day for two months, for a total of 30 injections; this treatment should be taken together with 2 tablets of Thymoenzym 2G Oral 350 mg twice a day (2 b.i.d.) taken daily before meals.Patient should be clinically evaluated monthly to ascertain whether to modify or maintain the treatment, as per the physician’s discretion.
Results: Once the first stages of treatment have been completed, the patient should notice an improvement in his response to related infections.

More Information

» Thymoenzym 2G
» Clinical Information and Pharmacology
» Mechanisms of Action
» Pharmacokinetics
» Indications
» Oncology
» Analysis
» Clinical Studies
» Bibliography
» Exclusively For Doctors